InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the full record of transactions filed by Valente Nancy. Director active across 2 companies, notably Myovant Sciences Ltd.. Aggregated, 7 filings have been recorded. Split: 0 buy · 3 sells. Total volume traded: €181k. History available since 26 October 2022. The latest transaction was disclosed on 2 May 2025 (Cession). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 条申报中的 7 条
Valente Nancy is a declarant linked to Xencor Inc, where she is EVP, Chief Development Officer, and to Myovant Sciences Ltd., where she is Director. She has 7 filings in total, and among the 7 sampled filings the sales amount to EUR 181415 between 2022-10-28 and 2025-05-06, with Cession as the most frequent transaction nature.